TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health has announced its first order from a well-known weight management company for its SlimBiome® and WellBiome® products, marking a significant step in its strategy to provide private label products. This order highlights the growing interest in natural alternatives to GLP1 in the weight management market, which is projected to grow significantly in the coming years. The company’s collaboration with international brands like Hydroxycut and LightLife further strengthens its position in the industry, potentially boosting future sales and shareholder value.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company that develops products aimed at modulating the human microbiome to help prevent and manage diseases. The company has created a diverse portfolio of microbiome-based ingredients and products, including SlimBiome®, WellBiome®, SweetBiotix®, and Microbiome Modulators. Additionally, OptiBiotix has interests in skincare and probiotics through its holdings in SkinBioTherapeutics PLC and ProBiotix Health plc, respectively.
Average Trading Volume: 259,273
Technical Sentiment Signal: Sell
Current Market Cap: £8.01M
See more insights into OPTI stock on TipRanks’ Stock Analysis page.